Compare AI & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AI | ENOV |
|---|---|---|
| Founded | 2009 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Fluid Controls |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2020 | 2008 |
| Metric | AI | ENOV |
|---|---|---|
| Price | $8.37 | $24.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 8 |
| Target Price | $20.00 | ★ $48.13 |
| AVG Volume (30 Days) | ★ 7.1M | 1.1M |
| Earning Date | 05-25-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.27 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $389,056,000.00 | N/A |
| Revenue This Year | N/A | $9.18 |
| Revenue Next Year | $11.36 | $4.69 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.27 | N/A |
| 52 Week Low | $9.53 | $21.00 |
| 52 Week High | $30.24 | $40.70 |
| Indicator | AI | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 28.97 | 59.42 |
| Support Level | N/A | $21.30 |
| Resistance Level | $14.34 | $32.29 |
| Average True Range (ATR) | 0.75 | 1.00 |
| MACD | -0.08 | 0.36 |
| Stochastic Oscillator | 13.63 | 97.82 |
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.